Press Releases

SEATTLE, Jan. 9, 2020 /PRNewswire/ -- Presage Biosciences, a biotechnology company pioneering a new cancer drug development approach using its CIVO®  intratumoral microdosing platform, announced today that the U.S. Food and Drug Administration (FDA) has approved its first Exploratory Investigational New Drug (IND) application for a Phase 0 study utilizing i

NEW YORK, Jan. 9, 2020 /PRNewswire/ -- Ruder Finn Group, a leading independent global creative and communications agency, today announced the appointment of Christie Anbar to Managing Director, Global Healthcare. In her new role, Anbar will build on the agency's rich heritage and leadership in partnering with clients that transform the

NEW YORK, Jan. 9, 2020 /PRNewswire/ -- Omnicom Public Relations Group (OPRG), a division of Omnicom Group (NYSE: OMC) announced today a strategic alliance with LaVoieHealthScience (LHS) to bring global clients a broader set of integrated health- and science-experienced teams. The alliance combines the scale of OPRG with LHS's capabilities in strategic communications, inc

BRIDGEWATER, N.J., Jan. 9, 2020 /PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced that Will Lewis, Chairman and Chief Executive Officer of Insmed, will present at the 38th Annual J.P. Morgan Healthcare Conference in

BRANFORD, Conn., Jan. 9, 2020 /PRNewswire/ -- IsoPlexis, the leader in single-cell functional proteomics, has announced today that it has raised an additional $20 million in its Series C financing, bringing the entire Series C round to $45 million. The funding will continue to drive the global commercial expansi

BREA, Calif., Jan. 9, 2020 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) ("Envista") will report financial results for its fourth quarter 2019 on Thursday, January 30, 2020, after market close.  Envista will discuss these results on a conference call on the same day beginning at 2:00 PM PT and l

DULUTH, Ga., Jan. 9, 2020 /PRNewswire/ -- Sebacia, Inc., a privately held commercial stage dermatology and aesthetics company, today provided a business update, first announcing an update to its leadership team. Mr. Chuck Abraham has been appointed Chief Executive Officer to lead the Company's commercial strategy and execution, includi

LOVELAND, Colo., Jan. 9, 2020 /PRNewswire/ -- Heska Corporation (NASDAQ: HSKA - News; "Heska" or the "Company"), a provider of advanced veterinary diagnostic and specialty products, announced today that the Company has acquired a 100% interest in CVM Diagnostico Veterinario, S.L. and CVM Ecografía, S.L. (referred to collectively as the "CVM Companies" or

SALT LAKE CITY, Jan. 9, 2020 /PRNewswire/ -- Clene Nanomedicine, Inc., a clinical-stage biopharmaceutical company, today announced the dosing of the first patient enrolled in the Phase 2 REPAIR-MS study with its lead nanocatalytic therapy, CNM-Au8, for the treatment of Multiple Sclerosis (MS). "The objective of the open-label, investigator-blinded REPAIR

MENLO PARK, Calif., Jan. 9, 2020 /PRNewswire/ -- Adicet Bio, Inc., a biopharmaceutical company focused on the development of allogeneic cell therapies for cancer using innovative gamma delta T cells, announced today that the company will present at the 38th Annual J.P. Morgan Healthcare Conference.